At a glance
- Originator AnorMED; Rega Institute for Medical Research
- Developer irsiCaixa Foundation
- Class Antivirals; Pyridines
- Mechanism of Action CXCR4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections